Recurrent Leflunomide-Induced Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Syndrome Despite Prolonged Steroid Taper: A Case Report.

Autor: Gayfield S; Internal Medicine, The University of Toledo, Toledo, USA., Busken J; Internal Medicine, The University of Toledo, Toledo, USA., Mansur S; Internal Medicine, The University of Toledo, Toledo, USA.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2022 Sep 19; Vol. 14 (9), pp. e29319. Date of Electronic Publication: 2022 Sep 19 (Print Publication: 2022).
DOI: 10.7759/cureus.29319
Abstrakt: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe adverse drug reaction characterized primarily by nonspecific systemic symptoms such as fever, a classical rash, and eosinophilia. While this is an adverse reaction more often related to medications such as anticonvulsants, many drugs have been reported to be implicated in this event. We report a case of a 35-year-old male who developed DRESS syndrome within one month of beginning leflunomide therapy. Despite treatment with a prolonged steroid taper, he developed a flare-up with transaminitis less than two months after his initial hospitalization. Our patient was managed with steroid pulse therapy and cyclosporine, which resulted in an improvement of symptoms and transaminitis. To our knowledge, only nine previous cases of leflunomide-induced DRESS syndrome have been previously reported.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Gayfield et al.)
Databáze: MEDLINE